Results 21 to 30 of about 8,070,232 (284)

First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer [PDF]

open access: yes, 2013
AIM: To investigate activity, toxicity, and prognostic factors for survival of erlotinib and fixed dose-rate gemcitabine (FDR-Gem) in advanced pancreatic cancer.
Bria, E.   +9 more
core   +1 more source

Causes of Elevated Levels of Serum CA 19.9 in Patients without Prior Diagnosis of Malignant Disease

open access: yesSouthern Clinics of Istanbul Eurasia, 2019
INTRODUCTION[|]Serum CA 19.9 is commonly used as a tumor marker for diagnosis and follow-up of gastrointestinal malignancies. However, elevated levels can be found in various clinical conditions.[¤]METHODS[|]A total of 285 patients whose serum CA 19.9 ...
Selcuk Şeber   +4 more
doaj   +1 more source

Prognostic value of carcinoembryonic antigen and carbohydrate antigen 19–9 in periampullary cancer patients receiving pancreaticoduodenectomy

open access: yesAsian Journal of Surgery, 2021
Background: We assessed the use of serum concentrations of carbohydrate antigen (CA) 19–9 and carcinoembryonic antigen (CEA) measured during the preoperative diagnostic workup as prognostic factors for survival in patients with periampullary carcinoma ...
Sang Hun Park   +3 more
doaj   +1 more source

Elevation of CA 125 and CA 19–9 in patients with end-stage liver disease

open access: yesThe International Journal of Biological Markers, 2012
Background The serum tumor markers CA 19–9 and CA 125 are the serologic markers used for the monitoring of biliopancreatic and ovarian cancer, respectively. They are reported to be elevated in a variety of nonneoplastic clinical situations, including end-
Ashish Singhal   +7 more
doaj   +1 more source

Clinicopathological Characteristics and Prognosis of Diffuse Large B-Cell Lymphoma in Relation to CA-125 and CA 19-9 Expression

open access: yesJournal of Evidence-Based Integrative Medicine, 2023
Background: Some epithelial tumors express the carbohydrate antigen 125 (Cancer antigen-125, CA-125) and CA 19-9, especially ovarian and pancreatic tumors.
Abd AlRahman Mohammad Foda MD   +5 more
doaj   +1 more source

Relationship between serum calcium and CA 19-9 levels in colorectal cancer [PDF]

open access: yes, 2004
AIM: To examine the calcium metabolism of colorectal cancer (CRC) in patients with colorectal cancer and control patients. METHODS: Seventy newly diagnosed CRC patients were included.
Fuszek, Péter   +8 more
core   +1 more source

Value of carbohydrate antigen 19-9 in predicting response and therapy control in patients with metastatic pancreatic cancer undergoing first line therapy.

open access: yesFrontiers in Oncology, 2013
Background:Serum carbohydrate antigen 19-9 (CA 19-9) has been shown to be a sensitive and specific serum marker for pancreatic cancer. Little has been published about correlations between baseline CA 19-9 level or changes to CA 19-9 level and median ...
Uwe ePelzer   +6 more
doaj   +1 more source

Biliary Peritonitis due to a Ruptured Amebic Liver Abscess Mimicking a Periampullary Tumor and Liver Metastases with the Elevation of CA 19-9 and CA 125: A Case Report

open access: yesGE: Portuguese Journal of Gastroenterology, 2018
Introduction: An amebic liver abscess is the most common presentation of extraintestinal amebiasis. This condition is the result of a parasite infection caused by Entamoeba histolytica.
Javiera Marin-Leiva   +3 more
doaj   +1 more source

CA 19-9: handle with care

open access: yesClinical Chemistry and Laboratory Medicine, 2013
Since its inception in the mid-1980s of the 20th century testing for carbohydrate antigen 19-9 (CA 19-9) has raised expectation for an earlier diagnosis and accurate monitoring of several malignant diseases. After almost 30 years, the available evidences have confirmed the appropriateness and usefulness of determining CA 19-9 levels as a prognostic ...
Galli C, BASSO, DANIELA, PLEBANI, MARIO
openaire   +3 more sources

Solid-pseudopapillary tumor of the pancreas: A single center experience [PDF]

open access: yes, 2016
open6noAim of this study was to review the institutional experience of solid-pseudopapillary tumors of the pancreas with particular attention to the problems of preoperative diagnosis and treatment.
Alberto Fantin   +5 more
core   +3 more sources

Home - About - Disclaimer - Privacy